Richie Kahn | Board Member
Canary Concierge

Day 2 - World Orphan Drug Congress USA 2026 @ 11:40

Building Patient Access Services 101

This session will explore what biopharma and advocacy organizations need to do to best prepare communities for what happens after approval. Often, people assume approval means immediate access, as though pharma can flip a switch and the drug miraculously becomes plentiful. Best practices for advocacy-led community education prior to approval; setting expectations; preparing communities to most effectively advocate in front of payers and more.